Published in Blood Weekly, March 22nd, 2001
"18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET) offers the advantage of metabolic imaging that is largely independent of morphologic criteria," noted Guy Jerusalem and colleagues in Belgium.
Jerusalem et al. found that 18F-FDG PET compared very favorably to conventional imaging methods, including chest X-rays and computed tomography (CT) scans.
18F-FDG PET had a sensitivity of 91%...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.